TABLE 2

Nerve conduction data in meters per second: effects of insulin or fidarestat or the p38 MAP kinase inhibitor, SB239063

MNCVSNCV
Controls63.8 ± 3.1a71.5 ± 4.7a
Diabetic49.1 ± 4.2b52.8 ± 5.5b
Diabetic + insulin62.5 ± 4.8a65.0 ± 4.8a
Controls59.2 ± 2.2a76.4 ± 3.7a
Diabetic50.7 ± 2.4b61.8 ± 4.2b
Diabetic + fidarestat62.0 ± 6.0a71.2 ± 3.4a
Controls65.8 ± 3.4a71.7 ± 3.1a
Diabetic47.6 ± 3.5b58.4 ± 4.1b
Diabetic + SB 23906369.9 ± 7.7a69.6 ± 6.5c
  • Data are means ± 1SE. Within-individual experiment levels of significance were a versus b, P < 0.01, and b versus c, P < 0.05.